J.W. de Fijter, Prof. dr.

University Medical Center Leiden
Dept of Nephrology
Leiden
Netherlands

Presentation(s) of this author

Wed, March 26th, 2014, 16:50 - 17:00

Elevated MBL levels in type 1 diabetic patients are reversed after simultaneous pancreas-kidney transplantation

Thu, March 27th, 2014, 9:30 - 9:40

Circulating MicroRNAs Correlate with Diabetic Nephropathy and Systemic Microvascular Damage and Normalize after Simultaneous Pancreas-Kidney Transplantation

Thu, March 27th, 2014, 9:50 - 10:00

Improved glycemic control and stable renal function following islet-after-kidney transplantation using an alemtuzumab-based induction regime in type 1 diabetes

Thu, March 27th, 2014, 10:20 - 10:30

Bone marrow and adipose tissue derived mesenchymal stromal cells have similar immunosuppressive capacities in vitro and in a humanized allograft rejection model.

Thu, March 27th, 2014, 10:30 - 12:30

The need for HLA incompatible kidney transplantation: Launch of a new national transplantation program in the Netherlands

Thu, March 27th, 2014, 10:30 - 12:30

The PROCARE Consortium: Towards an Improved Allocation Strategy for Kidney Allografts

Fri, March 28th, 2014, 9:10 - 9:20

The effect of CYP3A4*22, CYP3A5*3 and CYP3A combined genotypes on cyclosporine, everolimus and tacrolimus pharmacokinetics in renal transplant recipients.

Fri, March 28th, 2014, 9:40 - 9:50

Alemtuzumab induction in ABO-incompatible kidney transplant recipients

Fri, March 28th, 2014, 10:10 - 10:20

Donor genotype and intragraft expression of CYP3A5 reflect the response to steroid treatment during acute renal allograft rejection.

Fri, March 28th, 2014, 11:35 - 11:45

Differential expression and localization of tubular injury markers NGAL and KIM-1 in a rat model of renal ischemia/reperfusion injury

Fri, March 28th, 2014, 11:55 - 12:05

Differences in outcome after pancreas transplantation: a plea for a clearer definition of graft survival

Fri, March 28th, 2014, 13:30 - 16:00

Pro-Con discussie: Protocol biopten horen thuis in de dagelijkse klinische praktijk

J.W. de Fijter